AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

NVST · NYSE · Medical - Instruments & Supplies

Envista (NVST)

Provides dental technologies, consumables, and services through a multi-brand portfolio.

$24.19

vs last close+0.01 (+0.02%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Apr 2026	Q2 FY26Jul 2026
Revenue	631	646	624	633	601	653	617	682	670	751	706	731
Cost of revenue	267	307	266	303	284	280	281	312	295	338	315	324
Gross profit	364	339	358	330	317	373	336	370	375	413	390	407
	281	541	310	1,483	297	327	297	319	310	337	328	327
Research & development	22	20	23	24	26	27	25	28	28	32	30	30
	252	250	280	300	269	287	263	291	282	305	298	296
General & administrative	0	0	0	0	0	0	0	0	0	0	0	296
Other expenses	7	271	7	1,160	2	14	8	0	0	0	0	0
Operating income	83	−203	48	−1,153	21	46	39	51	65	76	63	80
	−48	−12	−13	−13	−11	−10	−10	−10	−15	−18	−10	−6
Interest expense	15	14	13	12	12	10	9	8	9	10	−7	9
Other non-operating income	−7	−271	−7	−1,160	−2	−14	1	2	6	8	18	−3
Income before tax	36	−215	35	−1,166	10	37	29	41	50	58	52	74
Income tax expense	14	2	12	−15	1	35	11	14	80	25	14	21
Net income from continuing operations	22	−217	24	−1,152	8	1	18	26	−30	33	39	54
Net income	22	−217	24	−1,152	8	1	18	26	−30	33	39	54
EPS, basic	$0.13	−$1.27	$0.14	−$6.69	$0.05	$0.01	$0.10	$0.16	−$0.18	$0.20	$0.24	$0.33
EPS, diluted	$0.12	−$1.27	$0.14	−$6.69	$0.05	$0.01	$0.10	$0.16	−$0.18	$0.20	$0.23	$0.33
Weighted average shares, basic	168	172	172	172	172	172	172	169	169	164	164	162
Weighted average shares, diluted	175	172	173	172	173	172	174	170	170	166	166	164
EBITDA	123	101	87	40	52	87	75	79	88	97	83	83
Depreciation & amortization	33	33	32	34	29	28	36	30	29	29	38	0
EBIT	90	68	55	6	23	60	38	49	59	68	45	83